Event Details
Date: 12 February 2027

Location name: London, UK; Hybrid

Location address: The Royal Society of Medicine
1 Wimpole Street
Marylebone
London
W1G 0AE

Contact: The Royal Society of Medicine

Tel: 020 7290 2991



Click to view dynamic map

Why attend?

  • Gain practical updates on current best practice in endourology and stone disease management
  • Explore how artificial intelligence and digital tools are beginning to influence clinical decision-making and patient pathways in endourology
  • Learn how quality improvement initiatives are shaping the delivery of stone services
  • Examine contemporary approaches to the management of benign prostatic enlargement
  • Take part in challenging case discussions exploring real-world clinical decision-making
  • Visit a dedicated technology exhibition showcasing the latest innovations in endourology.

Aims of the event

  • Provide an update on contemporary practice and emerging developments in endourology
  • Explore the evidence supporting current and evolving technologies in stone disease and bladder outlet obstruction
  • Support clinicians in applying quality improvement principles to enhance patient care.

Learning outcomes

By attending this meeting, participants will be able to:

  • Evaluate current technologies used in the management of stone disease and their evidence base
  • Apply best practice principles to the assessment and treatment of patients with stone disease
  • Evaluate emerging technologies and treatment options for benign prostatic enlargement and their evidence base.
  • Apply learning from case discussions and quality improvement initiatives to clinical practice.

Who should attend?

This meeting is suitable for:

  • Endourologists and urologists with an interest in stone disease
  • Consultants, GPs, SAS doctors and resident doctors involved in urological care
  • Urology specialist nurses and allied health professionals
  • Healthcare professionals with an interest in surgical innovation, technology and quality improvement.